Product Description
Introducing Erlogem 150 Tablet-an exquisite, prescription-only anti-cancer formulation crafted by Emcure Pharmaceuticals Ltd. With a transcendent strength of 150 mg Erlotinib Hydrochloride, each majestic, white oval tablet is designed for adults combating non-small cell lung cancer and pancreatic cancer. Erlogem 150 is brilliantly packaged in secure blister packs (30 tablets per box) and must be stored below 30C. Scarce in stock, this extraordinary medication promises precision-order now and grab yours to experience its potent benefits as prescribed by your physician. Do not miss this rare opportunity.
Material Feature and Specific Use
Erlogem 150 Tablet showcases a premium formulation with Erlotinib Hydrochloride as its core ingredient. Specially developed for oral administration, it serves as an effective anti-cancer medication, indicated for non-small cell lung cancer and pancreatic cancer in adults. Used as a precise, doctor-prescribed therapy, its brilliant efficacy and safety are enhanced by its diligent manufacturing and careful packaging. Ensure correct usage by following your physician's instructions and store the tablets in a cool, dry environment to preserve their majesty.
Domestic Market Reach and Payment Valuation
Erlogem 150 Tablet is widely available across India's main domestic market through certified service providers, suppliers, and traders. Flexible payment terms are offered to streamline your purchase experience. Upon your estimate request, transparent valuation is provided; easy drop-off and sample availability ensure confidence before making your order. Whether for urgent hospital needs or private clinics, Erlogem 150 delivers reliable access to critical care with trusted logistics and convenient service spanning India.
FAQ's of Erlogem 150 Tablet:
Q: How should Erlogem 150 Tablet be administered for optimal results?
A: Erlogem 150 Tablet must be taken orally, strictly on an empty stomach, either at least one hour before or two hours after a meal. Always follow the dosage and administration guidelines provided by your physician.
Q: What are the specific uses and recommended indications of Erlogem 150?
A: Erlogem 150 is primarily recommended for adults diagnosed with non-small cell lung cancer and pancreatic cancer. It serves as a targeted anti-cancer medication, prescribed by healthcare professionals for these conditions.
Q: What are the side effects and contraindications of Erlogem 150 Tablet?
A: Common side effects may include rash, diarrhea, appetite loss, and shortness of breath. Erlogem 150 is contraindicated in individuals known to be hypersensitive to Erlotinib or any of its excipients. Always inform your doctor of your medical history prior to use.
Q: Where is Erlogem 150 Tablet manufactured and who markets it?
A: Erlogem 150 Tablet is manufactured in India and marketed by Emcure Pharmaceuticals Ltd., ensuring quality and authenticity through reputable supply chains.
Q: What is the minimum order quantity and packaging details for Erlogem 150?
A: The minimum order quantity for Erlogem 150 is one box, each containing 30 tablets packaged in a secure blister pack. The product has a 24-month shelf life from its manufacture date.
Q: When is it appropriate to start treatment with Erlogem 150 Tablet?
A: Initiate treatment with Erlogem 150 only under the direct recommendation and prescription of your healthcare provider, who will evaluate your condition and determine necessity and suitability.